Evidence map›Paper›PMID 29899957›Full record

ArticleChemical science2018

Stapled peptides as a new technology to investigate protein-protein interactions in human platelets.

Jessica Iegre, Niaz S Ahmed, Josephine S Gaynord, Yuteng Wu, Kara M Herlihy, Yaw Sing Tan, Maria E Lopes-Pires, Rupam Jha, Yu Heng Lau, Hannah F Sore and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Recognition of ASF1 by Using Hydrocarbon-Constrained Peptides.Chembiochem : a European journal of chemical biology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Jessica IegreDepartment of Chemistry , University of Cambridge , CB2 1EW , UK . Email: spring@ch.cam.ac.uk.ORCID 0000-0002-9074-653X
Niaz S AhmedDepartment of Biomedical and Forensic Sciences , Anglia Ruskin University , CB1 1PT , UK . Email: nicholas.pugh@anglia.ac.uk.
Josephine S GaynordDepartment of Chemistry , University of Cambridge , CB2 1EW , UK . Email: spring@ch.cam.ac.uk.ORCID 0000-0002-4091-8030
Yuteng WuDepartment of Chemistry , University of Cambridge , CB2 1EW , UK . Email: spring@ch.cam.ac.uk.
Kara M HerlihyDiscovery Sciences , IMED Biotech Unit , AstraZeneca , Cambridge , UK.
Yaw Sing TanBioinformatics Institute , Agency for Science, Technology and Research (ASTAR) , 30 Biopolis Street, #07-01 Matrix , 13867 , Singapore.ORCID 0000-0002-2522-9421
Maria E Lopes-PiresDepartment of Biomedical and Forensic Sciences , Anglia Ruskin University , CB1 1PT , UK . Email: nicholas.pugh@anglia.ac.uk.
Rupam JhaDiscovery Sciences , IMED Biotech Unit , AstraZeneca , Cambridge , UK.
Yu Heng LauDepartment of Chemistry , University of Cambridge , CB2 1EW , UK . Email: spring@ch.cam.ac.uk.
Hannah F SoreDepartment of Chemistry , University of Cambridge , CB2 1EW , UK . Email: spring@ch.cam.ac.uk.
Chandra VermaBioinformatics Institute , Agency for Science, Technology and Research (ASTAR) , 30 Biopolis Street, #07-01 Matrix , 13867 , Singapore.
Daniel H O' DonovanOncology, IMED Biotech Unit , AstraZeneca , Cambridge , UK.ORCID 0000-0002-8400-2198
Nicholas PughDepartment of Biomedical and Forensic Sciences , Anglia Ruskin University , CB1 1PT , UK . Email: nicholas.pugh@anglia.ac.uk.ORCID 0000-0002-6916-4199
David R SpringDepartment of Chemistry , University of Cambridge , CB2 1EW , UK . Email: spring@ch.cam.ac.uk.ORCID 0000-0001-7355-2824
University of Cambridge · GBAnglia Ruskin University · GBAstraZeneca (United Kingdom) · GBAgency for Science, Technology and Research · SGThe University of Sydney · AU

Funding

British Heart Foundation PG/14/47/30912
6 · The paper itself

Abstract

Platelets are blood cells with numerous crucial pathophysiological roles in hemostasis, cardiovascular thrombotic events and cancer metastasis. Platelet activation requires the engagement of intracellular signalling pathways that involve protein-protein interactions (PPIs). A better understanding of these pathways is therefore crucial for the development of selective anti-platelet drugs. New strategies for studying PPIs in human platelets are required to overcome limitations associated with conventional platelet research methods. For example, small molecule inhibitors can lack selectivity and are often difficult to design and synthesise. Additionally, development of transgenic animal models is costly and time-consuming and conventional recombinant techniques are ineffective due to the lack of a nucleus in platelets. Herein, we describe the generation of a library of novel, functionalised stapled peptides and their first application in the investigation of platelet PPIs. Moreover, the use of platelet-permeable stapled Bim BH3 peptides confirms the part of Bim in phosphatidyl-serine (PS) exposure and reveals a role for the Bim protein in platelet activatory processes. Our work demonstrates that functionalised stapled peptides are a complementary alternative to conventional platelet research methods, and could make a significant contribution to the understanding of platelet signalling pathways and hence to the development of anti-platelet drugs.

Identifiers

PMID29899957
PMCPMC5969508
OpenAlexW2802410394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.